MELANOMAP Trademark

Trademark Overview

On Monday, August 7, 2017, a trademark application was filed for MELANOMAP with the United States Patent and Trademark Office. The USPTO has given the MELANOMAP trademark a serial number of 87558676. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by Frontier Diagnostics, LLC. The MELANOMAP trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical diagnostic services to others, namely, assay analyses for the diagnosis of cancer
melanomap

General Information

Serial Number87558676
Word MarkMELANOMAP
Filing DateMonday, August 7, 2017
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6185490
Registration DateTuesday, October 27, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Goods and ServicesProviding medical diagnostic services to others, namely, assay analyses for the diagnosis of cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 10, 2017
Primary Code044
First Use Anywhere DateFriday, September 14, 2018
First Use In Commerce DateFriday, September 14, 2018

Trademark Owner History

Party NameFrontier Diagnostics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSmyrna, TN 37167
Party NameFrontier Diagnostics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSmyrna, TN 37167
Party NameFrontier Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSmyrna, TN 37167

Trademark Events

Event DateEvent Description
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, September 24, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 23, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 3, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 27, 2020USE AMENDMENT FILED
Thursday, August 27, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, August 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2020EXTENSION 5 GRANTED
Wednesday, July 8, 2020EXTENSION 5 FILED
Tuesday, August 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 8, 2020TEAS EXTENSION RECEIVED
Wednesday, January 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2020EXTENSION 4 GRANTED
Monday, January 6, 2020EXTENSION 4 FILED
Monday, January 6, 2020TEAS EXTENSION RECEIVED
Tuesday, July 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2019EXTENSION 3 GRANTED
Friday, July 5, 2019EXTENSION 3 FILED
Friday, July 5, 2019TEAS EXTENSION RECEIVED
Saturday, January 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 10, 2019EXTENSION 2 GRANTED
Thursday, January 10, 2019EXTENSION 2 FILED
Thursday, January 10, 2019TEAS EXTENSION RECEIVED
Wednesday, July 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 2, 2018EXTENSION 1 GRANTED
Monday, July 2, 2018EXTENSION 1 FILED
Monday, July 2, 2018TEAS EXTENSION RECEIVED
Monday, July 2, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2017ASSIGNED TO EXAMINER
Thursday, August 10, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 10, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

melanomap assay analyses diagnosis cancer namely others medical diagnostic services providing